Novavax stock price target

NOVAVAX, INC. : NVAX Stock Price | MarketScreener

Mar 11, 2020 · In a note issued yesterday, Oppenheimer analyst Kevin DeGeeter reiterated his “outperform” call on Novavax stock, stating a price target of $13 a share on the $10 stock. DeGeeter explained his continued optimism about Novavax by pointing to “two important announcements related to [Novavax’s] COVID-19 vaccine program,” released yesterday. Digging Up the Details on Novavax, Inc. (NVAX) | US Post News Mar 16, 2020 · On Friday, shares of Novavax, Inc. (NASDAQ:NVAX) marked $8.41 per share versus a previous $9.29 closing price. With having a -9.47% loss, an insight into the fundamental values of Novavax, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. NVAX Stock Quote - Novavax, Inc. Common Stock Price - Nasdaq Mar 27, 2020 · Stock quote for Novavax, Inc. Common Stock Common Stock (NVAX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Novavax: Rising From The Depths (NASDAQ:NVAX) | Seeking Alpha Sep 03, 2019 · The past six months have been challenging for Novavax (NASDAQ:NVAX) investors due to ResVax missing its primary endpoint and the company executing a reverse stock split “r/s”.Recently, the

21 Jan 2020 on Novavax (NVAX – Research Report) today and set a price target of Mamtani covers the Healthcare sector, focusing on stocks such as 

Novavax, Inc. is said to have a 12-month price target set at $13.75. That means that the stock has a strong potential to acquire 5.81% increase from the current trading price. Novavax, Inc. [NASDAQ:NVAX]: Analyst Rating and Earnings. Its stock price has been found in the range of 3.54 to 43.40. This is compared to its latest closing price of $7.95. Novavax, Inc. [NVAX] – How low can NASDAQ:NVAX go? A ... Novavax, Inc. is said to have a 12-month price target set at $13.75. That means that the stock has a strong potential to acquire 4.53% increase from the current trading price. Novavax, Inc. [NASDAQ:NVAX]: Analyst Rating and Earnings. Its stock price has been found in the range of 3.54 to 43.40. This is compared to its latest closing price of $7.95. NVAX - Novavax, Inc. Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Novavax, Inc. (NASDAQ: NVAX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. NVAX Novavax, Inc. — Stock Price and Discussion | Stocktwits

NVAX:NASDAQ GS Stock Quote - Novavax Inc - Bloomberg Markets

Novavax (NASDAQ:NVAX) had its target price upped by B. Riley from $12.00 to $16.00 in a report released on Friday morning, The Fly reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. NVAX has been the subject of a number of other research reports. B. Riley FBR Resumed Novavax Inc. [NVAX]. What else is ... The new note on the price target was released on August 14, 2019, representing the official price target for Novavax Inc. stock. Previously, the target price had yet another drop from $4.50 to $0.25, while Piper Jaffray kept a Underweight rating on NVAX stock. Novavax Stock Forecast: down to 9.515 USD? - NVAX Stock ... Novavax, Inc () Stock Market infoRecommendations: Buy or sell Novavax stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Novavax share forecasts, stock quote and buy / sell signals below.According to present data Novavax's NVAX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Oppenheimer Backs Novavax as a Coronavirus Play - TipRanks ... Mar 11, 2020 · In a note issued yesterday, Oppenheimer analyst Kevin DeGeeter reiterated his “outperform” call on Novavax stock, stating a price target of $13 a share on the $10 stock. DeGeeter explained his continued optimism about Novavax by pointing to “two important announcements related to [Novavax’s] COVID-19 vaccine program,” released yesterday.

Find the latest analyst research for Novavax, Inc. Common Stock (NVAX) at Nasdaq.com. Back to NVAX Overview. Analyst price targets provided by TipRanks.

Novavax, Inc. is said to have a 12-month price target set at $13.75. That means that the stock has a strong potential to acquire 5.81% increase from the current trading price. Novavax, Inc. [NASDAQ:NVAX]: Analyst Rating and Earnings. Its stock price has been found in the range of 3.54 to 43.40. This is compared to its latest closing price of $7.95. Novavax, Inc. [NVAX] – How low can NASDAQ:NVAX go? A ... Novavax, Inc. is said to have a 12-month price target set at $13.75. That means that the stock has a strong potential to acquire 4.53% increase from the current trading price. Novavax, Inc. [NASDAQ:NVAX]: Analyst Rating and Earnings. Its stock price has been found in the range of 3.54 to 43.40. This is compared to its latest closing price of $7.95. NVAX - Novavax, Inc. Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Novavax, Inc. (NASDAQ: NVAX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. NVAX Novavax, Inc. — Stock Price and Discussion | Stocktwits

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment.

Novavax expects NanoFlu data in Q1 of 2020 - Washington ... Nov 08, 2019 · Novavax's stock price Friday didn't show any similar anxiousness on the part investors. The stock fluctuated only modestly, opening up 2.43% at …

NOVAVAX INC. DL-,01 (NVV1.BE) Stock Price, Quote, History ... Find the latest NOVAVAX INC. DL-,01 (NVV1.BE) stock quote, history, news and other vital information to help you with your stock trading and investing. The average price target is $21 and NVAX Stock Price | Novavax Inc. Stock Quote (U.S.: Nasdaq ... Novavax stock rises on funding for COVID-19 vaccine trial Shares of Novavax Inc. were up 8% in trading on Tuesday after the company said it had received $4 million from the Coalition for Epidemic Why Novavax Shares Are Falling Today | The Motley Fool